{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T21:15:11Z","timestamp":1783458911264,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32071261"],"award-info":[{"award-number":["32071261"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["KFJJ-2024-04"],"award-info":[{"award-number":["KFJJ-2024-04"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011382","name":"State Key Laboratory of Urban Water Resource and Environment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011360","name":"State Key Laboratory of Natural Medicines","doi-asserted-by":"publisher","award":["SKLNMKF202506"],"award-info":[{"award-number":["SKLNMKF202506"]}],"id":[{"id":"10.13039\/501100011360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003472","name":"Harbin Institute of Technology","doi-asserted-by":"publisher","award":["ES202409"],"award-info":[{"award-number":["ES202409"]}],"id":[{"id":"10.13039\/501100003472","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neuropharm.2026.111065","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:11:48Z","timestamp":1780503108000},"page":"111065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Endomorphin analogs CEMR-1 and CEMR-2 administered intravenously display potent antinociception with limited tolerance in acute, neuropathic and inflammatory pain"],"prefix":"10.1016","volume":"298","author":[{"given":"Si-yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-jing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ren","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai-yun","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1600-0024","authenticated-orcid":false,"given":"Yu-Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111065_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109439","article-title":"Endomorphin analog ZH853 shows low reward, tolerance, and affective-motivational signs of withdrawal, while inhibiting opioid withdrawal and seeking","volume":"227","author":"Amgott-Kwan","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111065_bib2","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s11064-018-2542-7","article-title":"The peripheral versus central antinociception of a novel opioid agonist: acute inflammatory pain in rats","volume":"43","author":"Balogh","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2026.111065_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd.2015.21","article-title":"From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2026.111065_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinme.2025.100330","article-title":"Opioid analgesics: managing the predictable","volume":"25","author":"Barnes","year":"2025","journal-title":"Clin. Med."},{"key":"10.1016\/j.neuropharm.2026.111065_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.brainresbull.2019.12.001","article-title":"The role of the endogenous neurotransmitters associated with neuropathic pain and in the opioid crisis: the innate pain-relieving system","volume":"155","author":"B\u00e1n","year":"2020","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2026.111065_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2025.171422","article-title":"Endogenous opiates and behavior: 2024","volume":"191","author":"Bodnar","year":"2025","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2026.111065_bib7","doi-asserted-by":"crossref","first-page":"18064","DOI":"10.1021\/acs.jmedchem.5c01126","article-title":"Current nonopioid small molecule approaches toward the treatment of neuropathic pain","volume":"68","author":"Cioffi","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.111065_bib8","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0140-6736(19)30430-1","article-title":"Perioperative opioid analgesia-when is enough too much? A review of opioid-induced tolerance and hyperalgesia","volume":"393","author":"Colvin","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2026.111065_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107992","article-title":"MEL endomorphins act as potent inflammatory analgesics with the inhibition of activated non-neuronal cells and modulation of pro-inflammatory cytokines","volume":"168","author":"Cui","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111065_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1568026615666150817103635","article-title":"Strategies to improve bioavailability and in vivo efficacy of the endogenous opioid peptides Endomorphin-1 and Endomorphin-2","volume":"16","author":"De Marco","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.111065_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1297931","article-title":"The role of neuroinflammation in the transition of acute to chronic pain and the opioid-induced hyperalgesia and tolerance","volume":"14","author":"Echeverria-Villalobos","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111065_bib12","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.jpain.2017.08.007","article-title":"Novel endomorphin analogs are more potent and longer-lasting analgesics in neuropathic, inflammatory, postoperative, and visceral pain relative to morphine","volume":"18","author":"Feehan","year":"2017","journal-title":"J. Pain"},{"key":"10.1016\/j.neuropharm.2026.111065_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/bip.20421","article-title":"Oligoarginine vectors for intracellular delivery: design and cellular-uptake mechanisms","volume":"84","author":"Futaki","year":"2006","journal-title":"Biopolymers"},{"key":"10.1016\/j.neuropharm.2026.111065_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.14341\/probl10364","article-title":"Endomorphins: structure, localization, immunoregulatory activity","volume":"66","author":"Gein","year":"2020","journal-title":"Probl. Endokrinol."},{"key":"10.1016\/j.neuropharm.2026.111065_bib15","doi-asserted-by":"crossref","first-page":"12929","DOI":"10.1021\/acs.jmedchem.0c01376","article-title":"Optimized opioid-neurotensin multitarget peptides: from design to structure-activity relationship studies","volume":"63","author":"Gonzalez","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.111065_bib16","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2401331121","article-title":"Sex bias in pain management decisions","volume":"121","author":"Guzikevits","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.111065_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0163-7258(00)00100-5","article-title":"Endomorphin-1 and endomorphin-2: pharmacology of the selective endogenous mu-opioid receptor agonists","volume":"88","author":"Horvath","year":"2000","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2026.111065_bib18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejmech.2014.12.049","article-title":"Synthesis and biological evaluations of novel endomorphin analogues containing \u03b1-hydroxy-\u03b2-phenylalanine (AHPBA) displaying mixed \u03bc\/\u03b4 opioid receptor agonist and \u03b4 opioid receptor antagonist activities","volume":"92","author":"Hu","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.111065_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpain.2024.104607","article-title":"Comparison of morphine and endomorphin analog ZH853 for tolerance and immunomodulation in a rat model of neuropathic pain","volume":"25","author":"Hunter","year":"2024","journal-title":"J. Pain"},{"key":"10.1016\/j.neuropharm.2026.111065_bib20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/0929867053362983","article-title":"Conformationally restricted peptides as tools in opioid receptor studies","volume":"12","author":"Janecka","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.111065_bib21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","article-title":"Neuroinflammation and central sensitization in chronic and widespread pain","volume":"129","author":"Ji","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2026.111065_bib22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.pbb.2006.05.005","article-title":"Potent in vivo antinociception and opioid receptor preference of the novel analogue [Dmt1]endomorphin-1","volume":"84","author":"Jinsmaa","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2026.111065_bib23","doi-asserted-by":"crossref","first-page":"7435","DOI":"10.2174\/138161281942140105165646","article-title":"Hybrid opioid\/non-opioid ligands in pain research","volume":"19","author":"Kleczkowska","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2026.111065_bib24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pharmthera.2018.11.007","article-title":"Neurokinin-1 receptor-based bivalent drugs in pain management: the journey to nowhere?","volume":"196","author":"Kleczkowska","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2026.111065_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejps.2016.07.009","article-title":"Biological evaluation and molecular docking studies of AA3052, a compound containing a \u03bc-selective opioid peptide agonist DALDA and d-Phe-Phe-d-Phe-Leu-Leu-NH2, a substance P analogue","volume":"93","author":"Kowalczyk","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.neuropharm.2026.111065_bib26","doi-asserted-by":"crossref","first-page":"15214","DOI":"10.1016\/S0021-9258(18)48160-4","article-title":"Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport","volume":"262","author":"Kumagai","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.111065_bib27","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1111\/bph.70178","article-title":"A novel peptide-fentanyl conjugate with \u03bc-opioid and neuropeptide FF receptor agonism produces antinociception with limited side effects in male mice","volume":"182","author":"Li","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111065_bib28","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/med.20222","article-title":"Endomorphins: potential roles and therapeutic indications in the development of opioid peptide analgesic drugs","volume":"32","author":"Liu","year":"2012","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.neuropharm.2026.111065_bib29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJMra1800222","article-title":"Opioid tolerance in critical illness","volume":"380","author":"Martyn","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2026.111065_bib30","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1016\/j.bja.2019.03.023","article-title":"Chronic pain: a review of its epidemiology and associated factors in population-based studies","volume":"123","author":"Mills","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2026.111065_bib31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrn2606","article-title":"Animal models of pain: progress and challenges","volume":"10","author":"Mogil","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111065_bib32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pain.2010.07.015","article-title":"The necessity of animal models in pain research","volume":"151","author":"Mogil","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2026.111065_bib33","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ejmech.2015.12.012","article-title":"Synthesis of mixed MOR\/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration","volume":"109","author":"Perlikowska","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.111065_bib35","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2174\/1389450111314070008","article-title":"Cyclization in opioid peptides","volume":"14","author":"Piekielna","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.neuropharm.2026.111065_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1133961","article-title":"Functional selectivity of EM-2 analogs at the mu-opioid receptor","volume":"14","author":"Piekielna-Ciesielska","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111065_bib36","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.lfs.2013.09.016","article-title":"Novel fentanyl-based dual \u03bc\/\u03b4-opioid agonists for the treatment of acute and chronic pain","volume":"93","author":"Podolsky","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2026.111065_bib37","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41392-025-02361-1","article-title":"Pain management beyond opioids: a \u03b2-arrestin2-biased allosteric GPCR modulator opens new avenues for drug development","volume":"10","author":"Pottie","year":"2025","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.neuropharm.2026.111065_bib38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1749-6632.1999.tb07887.x","article-title":"Pain inhibition by endomorphins","volume":"897","author":"Przew\u0142ocki","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2026.111065_bib39","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1097\/j.pain.0000000000001939","article-title":"The revised international association for the study of pain definition of pain: concepts, challenges, and compromises","volume":"161","author":"Raja","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2026.111065_bib40","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.2174\/0929867323666160427123005","article-title":"Cyclic opioid peptides","volume":"23","author":"Remesic","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.111065_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25184260","article-title":"Design, synthesis and functional analysis of cyclic opioid peptides with dmt-tic pharmacophore","volume":"25","author":"Sarkar","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2026.111065_bib42","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1021\/acs.jmedchem.9b01963","article-title":"Potent, efficacious, and stable cyclic opioid peptides with long lasting antinociceptive effect after peripheral administration","volume":"63","author":"Stefanucci","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.111065_bib43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejmech.2015.11.028","article-title":"Multitarget opioid ligands in pain relief: new players in an old game","volume":"108","author":"Turnaturi","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.111065_bib44","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.2174\/0929867311320220002","article-title":"Endomorphin derivatives with improved pharmacological properties","volume":"20","author":"Varamini","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.111065_bib45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fphar.2013.00155","article-title":"Lipid- and sugar-modified endomorphins: novel targets for the treatment of neuropathic pain","volume":"4","author":"Varamini","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111065_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2021.105222","article-title":"Chronic pain and neuroinflammation","volume":"88","author":"Vergne-Salle","year":"2021","journal-title":"Jt. Bone Spine"},{"key":"10.1016\/j.neuropharm.2026.111065_bib47","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41380-020-0661-4","article-title":"The changing opioid crisis: development, challenges and opportunities","volume":"26","author":"Volkow","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111065_bib48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.peptides.2010.10.024","article-title":"Synthesis and antinociceptive effects of endomorphin-1 analogs with C-terminal linked by oligoarginine","volume":"32","author":"Wang","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2026.111065_bib49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neuropharm.2016.12.026","article-title":"Endomorphin-2 analogs with C-terminal esterification produce potent systemic antinociception with reduced tolerance and gastrointestinal side effects","volume":"116","author":"Wang","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111065_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176775","article-title":"BNT12, a novel hybrid peptide of opioid and neurotensin pharmacophores, produces potent central antinociception with limited side effects","volume":"978","author":"Wang","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111065_bib51","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuropharm.2016.03.017","article-title":"Pharmacological characterization of EN-9, a novel chimeric peptide of endomorphin-2 and neuropeptide FF that produces potent antinociceptive activity and limited tolerance","volume":"108","author":"Wang","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111065_bib52","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/pm\/pnz122","article-title":"Dilemma of addiction and respiratory depression in the treatment of pain: a prototypical endomorphin as a new approach","volume":"21","author":"Webster","year":"2020","journal-title":"Pain Med."},{"key":"10.1016\/j.neuropharm.2026.111065_bib53","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1021\/acsmedchemlett.4c00315","article-title":"Cyclic glycopeptide analogs of Endomorphin-1 provide highly effective antinociception in Male and female mice","volume":"15","author":"Zadina","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2026.111065_bib54","doi-asserted-by":"crossref","first-page":"13394","DOI":"10.1021\/acs.jmedchem.1c00694","article-title":"Development of multifunctional and orally active cyclic peptide agonists of Opioid\/Neuropeptide FF receptors that produce potent, long-lasting, and peripherally restricted antinociception with diminished side effects","volume":"64","author":"Zhang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.111065_bib55","doi-asserted-by":"crossref","first-page":"16801","DOI":"10.1021\/acs.jmedchem.1c01631","article-title":"Novel cyclic endomorphin analogues with multiple modifications and oligoarginine vector exhibit potent antinociception with reduced opioid-like side effects","volume":"64","author":"Zhang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.111065_bib56","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/bph.16287","article-title":"Novel endomorphin analogues CEMR-1 and CEMR-2 produce potent and long-lasting antinociception with a favourable side effect profile at the spinal level","volume":"181","author":"Zhang","year":"2024","journal-title":"Br. J. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082600239X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082600239X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:31:15Z","timestamp":1783456275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082600239X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":56,"alternative-id":["S002839082600239X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111065","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endomorphin analogs CEMR-1 and CEMR-2 administered intravenously display potent antinociception with limited tolerance in acute, neuropathic and inflammatory pain","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111065"}}